Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer
Chiara Falcomatà(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Alessia Baccarini(Icahn School of Medicine at Mount Sinai), Alexander Tepper(Broad Institute), Sebastian R. Nielsen(Icahn School of Medicine at Mount Sinai), Gürkan Mollaoglu(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Hunter Potak(Icahn School of Medicine at Mount Sinai), Bhavya Singh(Cornell University), Maxime Dhainaut(Swiss Federal University for Vocational Education and Training SFUVET), Divya Chhamalwan(Icahn School of Medicine at Mount Sinai), Matthew D. Park(Icahn School of Medicine at Mount Sinai)
Cited by 1
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k